Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Enphase Energy (ENPH) Stock Rises 5% on Battery Deal

By Josh Enomoto, InvestorPlace Contributor

Although Enphase Energy garnered attention for an expanded partnership, ENPH stock could ultimately rise on geopolitical dynamics.

Why Are Bank Stocks BAC, BK, SCHW Trending Today?

By Josh Enomoto, InvestorPlace Contributor

Although bank stocks soared based on positive profitability results from higher rates, the forward outlook is less convincing.

7 Software Stocks to Buy on the Dip or Kick Yourself Later

By Josh Enomoto, InvestorPlace Contributor

While the broader technology sector suffered significantly this year, it also opens doors for speculating on software stocks to buy.

7 Best Bargain Stocks to Buy Now

By Josh Enomoto, InvestorPlace Contributor

Although suffering through market volatility when it happens is no fun, it also opens doors for the best bargain stocks to buy.

7 Best Blockchain Stocks to Buy for the Rest of 2022

By Josh Enomoto, InvestorPlace Contributor

Although the flailing cryptocurrency sector hurt many investors, right now, several of the best blockchain stocks to buy are on discount.

7 Under the Radar Dividend Growth Stocks With Upside Potential

By Josh Enomoto, InvestorPlace Contributor

With so many circumstances seemingly poised to go wrong, investors can find confidence in these under-the-radar dividend growth stocks.

Why Is Reata Pharmaceuticals (RETA) Stock Up 15% Today?

By Josh Enomoto, InvestorPlace Contributor

The FDA will not hold a meeting to review Reata Pharmaceuticals’ therapeutic for a rare disorder yet RETA stock soared. Here’s why.

Biomerica (BMRA) Stock Gets Boost From Walmart Sales Expansion

By Josh Enomoto, InvestorPlace Contributor

Although Biomerica announced encouraging product integration news, BMRA stock ultimately fell on broader market weakness.

7 Hypergrowth Stocks to Buy if You Are Feeling Greedy

By Josh Enomoto, InvestorPlace Contributor

If you laugh at the face of crushing volatility, then these hypergrowth stocks to buy could be right up your alley.

Revlon (REV) Stock Soars 30% on Short-Squeeze Hopes

By Josh Enomoto, InvestorPlace Contributor

Embattled cosmetics firm Revlon again made news as REV stock popped higher on Thursday, likely due to short-squeeze speculation.

Load More